Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $28.93 million versus the consensus estimate of $31.8 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.